Speciality Drugs, ‘Pharmerging’ Markets Key Drivers Of Global Rx Growth
This article was originally published in PharmAsia News
Executive Summary
IMS forecasts global pharmaceutical spending will reach $1.3 trillion in 2018, 30% higher than in 2013, with specialty drugs a key driver of forecast global growth. Within the major Asian markets, Japan has a generally low growth outlook while China will lead the ‘pharmerging’ countries with solid sales expansion, despite growing budget pressures.